About Us
Science
- Overview
- Pipeline
News & Events
Menu Menu

Sachs ELSF Forum

1 March 2024

17th Annual European Life Sciences CEO Forum
Zurich, Switzerland
28-29 February 2024

Share this entry

Share on X

https://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svg 0 0 dSpeidel https://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svg dSpeidel2024-03-01 09:26:292024-02-13 10:27:44Sachs ELSF Forum

MODULATING DNA DAMAGE RESPONSES TO CURE CANCER

Contact Us

Breakpoint Therapeutics GmbH
Essener Bogen 7
22419 Hamburg (Germany)

Telefon: +49 40 56081 180
E-mail: info@breakpointtx.com

Impressum

Registergericht: Hamburg
Registernummer: HRB 155717
Umsatzsteuer-Identifikationsnummer: DE 324 797 830

Geschäftsführer / Managing Directors
Dr. Daniel Speidel and Jonathan Hollick

Links

Privacy Statement

Breakpoint Therapeutics GmbH @ Website by FisherPaul

Privacy Statement

ESMO Targeted Anticancer Therapies Congress Breakpoint Therapeutics Announces Development Candidate Nomination and Start...